Responding to a question by BJP MLC Shashil Namoshi in the Assembly, Minister Sudhakar said
The Centre told the Supreme Court on Monday that all documents related to COVID-19 vaccines
The DCGI had approved Covovax for restricted use in emergency situations in adults on December 28 last year. The Drugs Controller General of India (DCGI)
India has recorded less than two COVID-19 cases per million people for several weeks now
According to an official statement released by Novovax, the vaccine, also known as NVX-CoV2373, is manufactured and marketed in India
Immunization Technical Support Unit (ITSU) provides techno-managerial support to Ministry of Health and Family Welfare (MoHFW) for scaling up the Universal Immunization Programme (UIP).